Work

FDA Approval of Respiratory Biosimilars—Turning the Tide of Cost‐Effectiveness?

Year: 2026

Type: article

Source: Otolaryngology

DOI: 10.1002/ohn.70227

Authors: Ashley L. Miller, Charles A. Elmaraghy, Casey D. Curtis, Vinay K. Rathi

Institutions: Nationwide Children's Hospital, The Ohio State University

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7142963713

FWCI: 2.279

Cites: 5

Cited by: 1

Related to: